<p>(<b>A</b>) Levels of cytokines differentially expressed between N2 and MM were evaluated as a function of the disease stage (i.e. active disease (AD), treatment (Tx), and remission (Rmss)). Median expression values for each cytokine are plotted. All cytokines levels were statistically different (p<0.01) between N2 and MM, but not between the stages of MM (p>0.05). With the exception of sIL-2R, MCP-1, and MIG, all cytokines were differentially expressed between N2 and MGUS (<0.03). (<b>B</b>) Expression of IL-17, the only cytokine expression of which is restored after treatment, for each stage of MM. The solid line denotes the trend of IL-17 expression over the course of the disease. Statistical significance: N2 vs. MGUS, p>0.05; N2 vs. a...
Aims: This study aimed to identify potential, non-invasive biomarkers for diagnosis and monitoring o...
Background: We previously reported algorithms based on clinical parameters and plasma cell character...
Aims: This study aimed to identify potential, non-invasive biomarkers for diagnosis and monitoring o...
Multiple myeloma (MM) is an incurable bone marrow malignancy of the B cell lineage. Utilizing multip...
<p>Differential expression of cytokines between N2, MGUS, and MM populations (fold change >1.25 with...
Multiple myeloma (MM) is an incurable bone marrow malignancy of the B cell lineage. Utilizing multip...
The aim of the study was to determine the levels of selected cytokines and chemokines in the serum o...
Multiple myeloma (MM) is the second most common hematological neoplasm. Cytokines, chemokines, and t...
<p>(A) Representative cytokine/chemokine antibody array associated with conditioned media (CM) from ...
BACKGROUND: A translational study in patients with myeloma to determine the utility of immune profil...
Persistence of chemoresistant minimal residual disease (MRD) plasma cells (PCs) is associated with i...
Objectives A clinical and laboratory study was performed to evaluate the plasmatic profile of cytoki...
Objectives A clinical and laboratory study was performed to evaluate the plasmatic profile of cytoki...
Multiple myeloma (MM) is an incurable plasma cell (PC) malignancy predominantly negative for the pro...
Biomarkers reliably predicting progression to multiple myeloma (MM) are lacking. Myeloma risk has be...
Aims: This study aimed to identify potential, non-invasive biomarkers for diagnosis and monitoring o...
Background: We previously reported algorithms based on clinical parameters and plasma cell character...
Aims: This study aimed to identify potential, non-invasive biomarkers for diagnosis and monitoring o...
Multiple myeloma (MM) is an incurable bone marrow malignancy of the B cell lineage. Utilizing multip...
<p>Differential expression of cytokines between N2, MGUS, and MM populations (fold change >1.25 with...
Multiple myeloma (MM) is an incurable bone marrow malignancy of the B cell lineage. Utilizing multip...
The aim of the study was to determine the levels of selected cytokines and chemokines in the serum o...
Multiple myeloma (MM) is the second most common hematological neoplasm. Cytokines, chemokines, and t...
<p>(A) Representative cytokine/chemokine antibody array associated with conditioned media (CM) from ...
BACKGROUND: A translational study in patients with myeloma to determine the utility of immune profil...
Persistence of chemoresistant minimal residual disease (MRD) plasma cells (PCs) is associated with i...
Objectives A clinical and laboratory study was performed to evaluate the plasmatic profile of cytoki...
Objectives A clinical and laboratory study was performed to evaluate the plasmatic profile of cytoki...
Multiple myeloma (MM) is an incurable plasma cell (PC) malignancy predominantly negative for the pro...
Biomarkers reliably predicting progression to multiple myeloma (MM) are lacking. Myeloma risk has be...
Aims: This study aimed to identify potential, non-invasive biomarkers for diagnosis and monitoring o...
Background: We previously reported algorithms based on clinical parameters and plasma cell character...
Aims: This study aimed to identify potential, non-invasive biomarkers for diagnosis and monitoring o...